Activity: FIPs from Affinity are produced to one or more inhibitor activity categories;
mild (1-10 BU/mL)
moderate (>10-50 BU/mL)
strong (>50-200 BU/mL)
The inhibitor potency is measured by standard Bethesda activity assay.
Consistency: Using antibodies of known neutralizing activity and factor-deficient plasma, much greater control of potency between lots is achieved.
| Order number |
Description |
Quantity |
Delivery time |
CE |
| TC 5159008 |
Factor VIII Inhibitor Plasma
|
5x1 ml |
7-10 days |
x |
| INH8-LDP-MO |
Factor VIII Inhibitor Plasma (Moderate), lyophilized
|
5x1 ml |
7-10 days |
|
| INH9-LDP-MI |
Factor IX Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH8-LDP-MI |
Factor VIII Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH8-LDP-STR |
Factor VIII Inhibitor Plasma (Strong), lyophilized
|
5x1 ml |
7-10 days |
|
| INH10-LDP-STR |
Factor X Inhibitor Plasma (Strong), lyophilized
|
5x1 ml |
7-10 days |
|
| INH11-LDP-MI |
Factor XI Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH11-LDP-MO |
Factor XI Inhibitor Plasma (Moderate), lyophilized
|
5x1 ml |
7-10 days |
|
| INH11-LDP-STR |
Factor XI Inhibitor Plasma (Strong), lyophilized
|
5x1 ml |
7-10 days |
|
| INH2-LDP-MI |
Factor II Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH5-LDP-MI |
Factor V Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH7-LDP-MI |
Factor VII Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH7-LDP-MO |
Factor VII Inhibitor Plasma (Moderate), lyophilized
|
5x1 ml |
7-10 days |
|
| INH7-LDP-STR |
Factor VII Inhibitor Plasma (Strong), lyophilized
|
5x1 ml |
7-10 days |
|
| INH10-LDP-MI |
Factor X Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|
| INH10-LDP-MO |
Factor X Inhibitor Plasma (Moderate), lyophilized
|
5x1 ml |
7-10 days |
|
| INH12-LDP-MI |
Factor XII Inhibitor Plasma (Mild), lyophilized
|
5x1 ml |
7-10 days |
|